This Swiss Bioinformatics Start-Up is Simplifying NGS and Data Driven Medicine for Hospitals

16/02/2016 - 2 minutes

As one of the most successful medical bioinformatics start-ups in Europe, Sophia Genetics (Switzerland) has now forged a partnership with a US nucleic acid synthesis company to facilitate the transition to Data Driven Medicine.  

sophia_genetics_idt_ngs_data_driven_medicineThis Swiss start-up led the way in European medical informatics when their software earned accreditation to store patient genomic data – a true privacy and ethics minefield for the field. This software and data could then be used as an In Vitro Diagnostics (IVD) device.

Hospitals generate incredible amounts of data from next generation sequencing (NGS), which is performed to run tests on patient tissue samples for disease. Because this data is hard to interpret manually, Sophia’s analytics aim to make genetic diagnostics easier.

The software is already used by more than 100 hospitals and Data Driven Medicine is a big potential disruptor in the Healthcare industry. Their innovative approach to medical informatics even put them at the 5th place in the TOP 100 Swiss Start-Up Ranking in 2015.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member